N-Methyl-D-aspartate (NMDA) Receptor NR1 Subunit Polyclonal Antibody
JHU scientists have developed a polyclonal antibody to the NR1 Subunit of the N-Methyl-D-aspartate (NMDA) Receptor. Proposed Use (Set) This technology encompasses an antibody specific for the NR1 Subunit of the NMDA Receptor. It has the potential to be commercialized as a biomarker for therapeutic, prophylactic or diagnostic use.
Type of Offer:
« More Tools Patents